The observation that the IDH status in patients with malignant astrocytic tumors has a significant prognostic relevance [8–10, 26–28] has led in recent years to significant modifications in the classification [6] and treatment of these tumors [21]. The gene discussed is IDH2; the disease is astrocytic tumor.